Verified earnings results
Rigel Pharmaceuticals Q3 2026 Earnings Results
Direct answer
Rigel Pharmaceuticals reported Q3 2026 results on November 5, 2026.
Revenue was 80,890,000. EPS missed the estimate by 23.83%.
The result is verified against Verified earnings source.
Verified earnings source
Get free Rigel Pharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Earnings date
- November 5, 2026
- Reported timing
- After the US market closes
- EPS estimate
- 0.8534
- Reported EPS
- 0.65
- Revenue
- 80,890,000
- EPS surprise
- EPS missed the estimate by 23.83%.
Explore related company data
Read the frequently asked questions.
When did Rigel Pharmaceuticals report Q3 2026 earnings?
Rigel Pharmaceuticals reported on November 5, 2026. The reported timing was after the us market closes.
What is the available EPS estimate for Rigel Pharmaceuticals?
The verified record provides an EPS estimate of 0.8534.
Has Rigel Pharmaceuticals reported the Q3 2026 result?
Revenue was 80,890,000. EPS missed the estimate by 23.83%.
Which source supports this Rigel Pharmaceuticals earnings record?
The earnings record identifies Verified earnings source as its source. Missing values are not estimated.